Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wockhardt Raids Competitors To Deal With Quality-Production Problems

This article was originally published in PharmAsia News

Executive Summary

Wockhardt has responded to a series of largely U.S. FDA actions potentially crippling its ability to sell into the vital U.S. market by replacing much of its management with people attracted from India competitors.

You may also be interested in...



Coronavirus Update: Lilly’s Antibody Plus Remdesivir Trial Abandoned

Combination of antibody therapy and Gilead's Veklury fails to show potential in patients with advanced disease.

Generic Drug Approvals Drop For The First Time In Five Years

The FDA’s generic drug program yearly performance report shows that generic drug approvals declined for the first time in five years in fiscal year 2020, and the agency also reported a lower number of ANDA submissions.

€200Bn And 400K Lives Saved Each Year? Deloitte Quantifies Value Of AI In European Health Care

While personal data security must be balanced againt the right to health, winning “trust” is the key to taking AI adoption to the next stage, says a new report focused on the European market.    

Topics

UsernamePublicRestriction

Register

GB150366

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel